Science and Technology Science and Technology
Tue, September 8, 2009
Mon, September 7, 2009
Fri, September 4, 2009

Mediware Information Systems: Mediware Adds Senior Executive to Management Team


Published on 2009-09-04 05:43:36 - Market Wire
  Print publication without navigation


LENEXA, KS--(Marketwire - September 4, 2009) - Mediware Information Systems, Inc. (NASDAQ: [ MEDW ]) announced today that Alan Wittmer has joined the company's executive team to lead corporate and business development initiatives. Mr. Wittmer joins Mediware from 3M where he was vice president of business development for the company's Health Information Systems (HIS) division.

"I'm very pleased to add Alan to our management team as Senior Vice President of Corporate Development," said Thomas Mann, Mediware's president and chief executive officer. "Alan has a broad professional history, a wealth of industry expertise and is acutely experienced in managing business development programs."

Mr. Wittmer has more than 19 years of experience in various healthcare information technology companies. "At 3M, Alan managed numerous acquisitions and a divestiture for the HIS division. He also oversaw 3M's HIS alliance program which grew revenue at a compounded rate of over 25% during the past three years," continued Mr. Mann.

In addition to more than a decade at 3M, Mr. Wittmer was one of two executives who launched PACE Health Management Systems where he led the development of an advanced bedside charting system for acute care hospitals. 3M acquired PACE in 1998. Prior to PACE Mr. Wittmer worked for Motorola, AT&T and Digital Equipment Corporation in various sales and marketing roles.

"Alan was instrumental in building the PACE start-up and played a key role in accelerating the 3M HIS division's growth. He will add critical expertise to support Mediware's' growth objectives," concluded Mr. Mann.

Mediware will release the full year results for the 2009 fiscal year on Wednesday September 9. The Company will host a teleconference call at 10:00 am Eastern Time (9:00 am Central Time) that day to discuss the results. There will be a question-and-answer session directly following the presentation of the results.

Participants may register in advance of the call online by going to [ http://www.directeventreg.com/registration/event/22948311 ]. The conference ID is 22948311. Participants without online access may call toll-free 888-869-1189 (direct dial 706-643-5902) to register for the call. Phone registrants should call in at least five minutes prior to the scheduled start of the call.

A replay of the call will be available after the call's completion for 5 days at 800-642-1687 (direct dial 706-645-9291). The conference ID is 22948311. After 5 days, the replay will be available on the company's web site: [ www.mediware.com ].

About Mediware

Mediware delivers interoperable best of breed software systems that integrate with electronic medical records to improve efficiencies and address safety concerns to enable healthcare organizations to improve care processes while decreasing costs. Core Mediware solutions include blood management technologies for hospitals and blood centers; medication management solutions for hospitals, behavioral health facilities, infusion and specialty pharmacy providers; and business intelligence based performance management solutions for clinical, regulatory and financial aspects of the broader healthcare market. For more information about Mediware products and services, visit our web site at [ www.mediware.com ].

Certain statements in this press release may constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the "Act") and in releases made by the SEC from time to time. Such forward-looking statements are not based on historical facts and involve known and unknown risks, uncertainties and other factors disclosed in the Company's Annual Report on Form 10-K for the year ended June 30, 2007, which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward-looking statements. The Company disclaims any obligation to update its forward-looking statements.

Contributing Sources